These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6111042)

  • 1. Characterization of haloperidol-mediated effects on rat striatal tyrosine hydroxylase.
    Pradhan S; Alphs L; Lovenberg W
    Neuropharmacology; 1981 Feb; 20(2):149-54. PubMed ID: 6111042
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of haloperidol on dopamine synthesis and tyrosine hydroxylase in striatal synaptosomes.
    Kapatos G; Zigmond MJ
    J Pharmacol Exp Ther; 1979 Mar; 208(3):468-75. PubMed ID: 34711
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic haloperidol: tolerance to the stimulating effect on striatal tyrosine hydroxylase.
    Tissari AH; Casu M; Gessa GL
    Life Sci; 1979 Jan; 24(5):411-6. PubMed ID: 34768
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term haloperidol treatment and factors affecting the activity of striatal tyrosine hydroxylase.
    Lovenberg W; Alphs L; Pradhan S; Bruckwick E; Levine R
    Adv Biochem Psychopharmacol; 1980; 24():9-15. PubMed ID: 6105810
    [No Abstract]   [Full Text] [Related]  

  • 5. Striatal tyrosine hydroxylase: comparison of the activation produced by depolarization and dibutyryl-cAMP.
    Simon JR; Roth RH
    Mol Pharmacol; 1979 Jul; 16(1):224-33. PubMed ID: 39245
    [No Abstract]   [Full Text] [Related]  

  • 6. Presynaptic regulation of tyrosine hydroxylase activity in rat striatal synaptosomes by dopamine analogs.
    Waggoner WG; McDermed J; Leighton HJ
    Mol Pharmacol; 1980 Jul; 18(1):91-9. PubMed ID: 6106156
    [No Abstract]   [Full Text] [Related]  

  • 7. The regulation of the kinetic state of striatal tyrosine hydroxylase and the role of postsynaptic dopamine receptors.
    Zivkovic B; Guidotti A; Costa E
    Brain Res; 1975 Jul; 92(3):516-21. PubMed ID: 240486
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuroleptics-induced changes of tyrosine hydroxylase activity in rat striatum in vitro and in vivo.
    Honma T; Hirose A
    Life Sci; 1979 May; 24(22):2023-30. PubMed ID: 37397
    [No Abstract]   [Full Text] [Related]  

  • 9. The regulation of striatal tyrosine hydroxylase. Effects of gamma hydroxybutric acid and healperidol.
    Zivkovic B; Guidotti A; Costa E
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 291(2):193-200. PubMed ID: 629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation and inactivation of striatal tyrosine hydroxylase: the effects of pH, ATP and cyclic AMP, S-adenosylmethionine and S-adenosylhomocysteine.
    Mann SP; Hill MW
    Biochem Pharmacol; 1983 Nov; 32(22):3369-74. PubMed ID: 6140010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of calcium on dopamine synthesis and tyrosine hydroxylase activity in rat striatum.
    Kapatos G; Zigmond MJ
    J Neurochem; 1982 Aug; 39(2):327-35. PubMed ID: 6123555
    [No Abstract]   [Full Text] [Related]  

  • 12. Dopaminergic agonist and antagonist effects on striatal tyrosine hydroxylase distribution.
    Smith CP; Ellis DB; Meyerson LR
    Life Sci; 1981 Jan; 28(2):193-7. PubMed ID: 6114374
    [No Abstract]   [Full Text] [Related]  

  • 13. Opiate-receptors in substantia nigra: role in the regulation of striatal tyrosine hydroxylase activity.
    Gale K; Moroni F; Kumakura K; Guidotti A
    Neuropharmacology; 1979 Apr; 18(4):427-30. PubMed ID: 36574
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulatory mechanisms of dopamine biosynthesis at the tyrosine hydroxylase step.
    Goldstein M
    Ann N Y Acad Sci; 1984; 430():1-5. PubMed ID: 6146282
    [No Abstract]   [Full Text] [Related]  

  • 15. Antagonistic effects of apomorphine and haloperidol on rat striatal synaptosomal tyrosine hydroxylase.
    Christiansen J; Squires RF
    J Pharm Pharmacol; 1974 May; 26(5):367-9. PubMed ID: 4152779
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence for a role of nigral gamma-aminobutyric acid and substance P in the haloperidol-induced activation of striatal tyrosine hydroxylase.
    Gale K; Costa E; Toffano G; Hong JS; Guidotti A
    J Pharmacol Exp Ther; 1978 Jul; 206(1):29-37. PubMed ID: 26799
    [No Abstract]   [Full Text] [Related]  

  • 17. Stimulation of tyrosine hydroxylase activity by cyclic AMP in synaptosomes and in soluble striatal enzyme preparations.
    Goldstein M; Bronaugh RL; Ebstein B; Roberge C
    Brain Res; 1976 Jun; 109(3):563-74. PubMed ID: 6124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of kinetic constant of striatal tyrosine hydroxylase elicited by neuroleptics that impair the function of dopamine receptors.
    Zivkovic B; Guidotti A
    Brain Res; 1974 Oct; 79(3):505-9. PubMed ID: 4153770
    [No Abstract]   [Full Text] [Related]  

  • 19. Intranigral application of substance P antagonists prevents the haloperidol-induced activation of striatal tyrosine hydroxylase.
    Melis MR; Gale K
    Naunyn Schmiedebergs Arch Pharmacol; 1984 May; 326(1):83-6. PubMed ID: 6206401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of dopamine and of apomorphine on dB-cAMP induced stimulation of synaptosomal tyrosine hydroxylase.
    Ebstein B; Roberge C; Tabachnick J; Goldstein M
    J Pharm Pharmacol; 1974 Dec; 26(12):975-7. PubMed ID: 4156865
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.